United Kingdom · Seed startup

Who invested in Cumulus Oncology

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$17Mraised across 2 rounds since 2022, from 2 sources

$5.6MRound$12MSeed

Latest round: Seed, $12MJan 2024
Step-upi: 2.1×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

202220232024

$5.6MRound$12MSeed

First round: Round, $5.6M
Biggest round: $12M
Between rounds: 22 months

The rounds

Jan 2024
Seed$12M1 new
- Scottish Enterprise
Source recorded
Feb 2022
Round$5.6M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

Cumulus Oncology filed 2 raises, $17M in all. Filings say how much was sold and to how many investors; they never name the investors.

Dec 2023$11MUK share allotment
Feb 2022$5.6MUK share allotment

Founders and team

From Cumulus Oncology's own website: 1 founder, 4 on the team.

Dr Clare WareingFounder & CEO

Clare DorisChief Development Officer
James FairChief Financial Officer
Laura GallagherSenior Operations Lead (Program Management)
Scott DoakGroup Finance Director

Everyone who backed them

Scottish EnterpriseGovernment1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Cumulus Oncology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.